ZN Mexico II

ZN Mexico II, L.P. is a private equity fund managed by Nexxus Capital, a leading alternative asset management firm in Mexico. Established in 2002, the fund was a strategic partnership between Nexxus and investment vehicles associated with Sam Zell (Zell/Nexxus), focusing on providing growth capital to middle-market companies in Mexico. It is highly significant in the healthcare and life sciences sector for its 30% equity investment in Genomma Lab Internacional, a major Mexican pharmaceutical and personal care company. ZN Mexico II played a pivotal role in Genomma Lab's institutionalization and its successful initial public offering (IPO) on the Mexican Stock Exchange in 2008. The fund's investment strategy emphasized enhancing corporate governance and operational efficiency to prepare family-owned businesses for public markets.